Annual Congress Copenhagen 2005

Saturday, 17.09.2005
Sunday, 18.09.2005
Monday, 17.09.2005
Tuesday, 20.09.2005
Wednesday, 21.09.2005

Citations should be made in the following way: Authors. Title. Eur Respir J 2005; 26: Suppl. 49, abstract number.

Material from 2005:

4063 Abstracts
739 Slide presentations
213 Webcasts
93 Handouts

Material from 2005: Show

Gene expression, receptors and markers in lung cancer

Poster Discussion
Chairs: C. Mascaux (Brussels, Belgium), G. Buccheri (Cuneo, Italy)

Download all media

Gene expression profile in lung adenocarcinoma and non-cancerous lung tissue D. Stav, S. Blum, J. Sandbank, A. Reiner, L. Diamon, J. Kumm, G. Ben Ari, M. Feldman, J. Hillel (Zerrifin, Rehovot, Israel; Palo Alto, United States Of America)
COX-2 expression during early lung squamous cell carcinomas oncogenesis C. Mascaux, B. Martin, J. M. Verdebout, V. Ninane, J. P. Sculier (Brussels, Belgium)
Microfluidics and HPLC analyses of novel lung cancer genes identified by arbitrarily primed PCR R. M. Yusoff, R. Harun, M. S. M. Said (Kuala Lumpur, Shah Alam, Malaysia)
Expression of endothelin receptor subtypes in different pulmonary tumours S. Blouquit, A. Régnier, L. Dannhoffer, U. Zimmermann, B. Franc, T. Chinet (Boulogne, France)
Expression of alpha and beta estrogen, and progesterone receptors in adenocarcinoma and squamous lung cancer patients E. Radzikowska, R. Langfort, D. Giedronowicz, K. Roszkowski (Warsaw, Poland)
The expression rate of MAGE A1-6 and SSX4 in lung cancer K. C. Shin, J. H. Chung, K. H. Lee, C. H. Jeon, S. C. Lee, Y. J. Jeon, J. W. Park, T. H. Jung (Daegu, Republic Of Korea)
Influence of prostaglandin E₂ on cell surface urokinase-type plasminogen activator expression and activity in lung adenocarcinoma cell line K. Kobayashi, K. Takahashi, T. Odaka, H. Nakamura, T. Matsuoka (Ami, Japan)
The development of mutant P53 characterized by lung cancers contributes to their primary and acquired multi-drug resistance to chemotherapy J. Xu, C. Z. Zhou, T. Wang, C. H. Du, N. S. Zhong (Guangzhou, China)
Identification of differentially expressed genes in squamous cell carcinoma of the lung using differential display R. M. Yusoff, M. S. Mohamed Said, R. Harun (Kuala Lumpur, Shah Alam, Malaysia)
Loss of heterozygosity off the P16, P53 and APC gene in oral cavity exfoliate cytologic material among lung cancer patients J. Sanz-Ortega, J. Sanz-Espinera, S. Hernandez, M. Saez, F. Roig-Vázquez, A. Muñoz, J. Granda-Orive, L. Callol-Sánchez (Madrid, Spain)
Dysplasia and aberrant methylation profiles in risk and lung cancer patients J. A. Lloret, A. Rosell, N. Rodríguez, E. Arellano, S. Calvo, M. T. Fernández, J. Ruiz, J. L. Ramírez, J. Gupta, M. Taron, R. Rosell (Barcelona, Spain)
Polymorphisms in the interleukin-10 gene promoter are associated with susceptibility to non-small cell lung cancer (NSCLC) S. J. Liang, Y. C. Lin, Y. L. Lee, H. L. Chiou, T. C. Hsia, C. M. Shih (Taichung, Taiwan, Province Of China)
Fucosylation of serum glycoproteins in lung cancer B. Kossowska, M. Ferens-Sieczkowska, E. Passowicz-Muszynska, R. Jankowska, R. Gancarz (Wroclaw, Poland)
Prognostic significance and correlation between Akt phosphorylation and loss of PTEN protein expression in non-small cell lung cancer J. M. Tang, Q. Y. He, X. J. Chang (Beijing, China)
Early lung carcinogenesis: MDM2 expression in bronchial preneoplastic lesions and its correlation with p53 C. Mascaux, A. Haller, B. Martin, F. Feoli, V. Ninane, J. P. Sculier (Brussels, Belgium)
Expression of CD44v5 in epidermoid lung cancer R. Melchor, I. Fernandez-Ormaechea, A. Ortega, A. Ruibal (Madrid, Santiago de Compostela, Spain)
Soluble non-invasive markers in non-small cell lung cancer G. E. Carpagnano, O. Resta, G. Di Gioia, P. Bonfitto, T. Giliberti, I. Ventura, M. P. Foschino Barbaro (Foggia, Bari, Italy)
Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in NSCLC M. S. Kim, S. J. Kim, S. Y. Lee, S. S. Kwon, Y. K. Kim, K. H. Kim, H. S. Moon, J. S. Song, S. H. Park, S. W. Moon, Y. P. Wang (Seoul, Republic Of Korea)
Tumor specific MUC1 expression in operable lung cancer correlates with improved survival R. Wiewrodt, A. Kummel, K. Single, F. Bittinger, S. Goletz, M. Sebastian, R. Buhl (Mainz, Germany)
Quality of life in lung cancer patients: preliminary results of a multi-professional interview for diagnosis disclosure (MIDD) J. M. Vernejoux, A. Izadifar, L. Grandon, A. Decouvelaere, M. Josse, A. Taytard (Pessac, France)